Unveiling the Process of Transforming Antimicrobial Therapy Through CRISPR-assisted Engineering of Phages
Time: 1:00 pm
day: Pre-Conference Day Track B PM
- Creating supercharged synthetic phages as highly effective weapons in the fight against multidrug-resistant bacterial infections
- Benefits of engineering natural phages to broaden their host range, minimize resistance and improve efficacy
- Updates from the world’s first clinical trial of orally dosing SNIPR001; a cocktail of CRISPR-armed phages
- How to identify optimal phage candidates for downstream engineering?